Bedaquiline Catalog No.:M8161-2 Euglycemic human islet transplantation model

Euglycemic human islet transplantation model and diabetic marginal mass human islet transplantation model

dark and at 0-4oC for short term (days to weeks) or -20oC for long term (months to years)

Smiles: CC1N=C(SC=1S(N)(=O)=O)N(C)C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1

Rat hepatocarcinoma cells (FAO) stimulated by fetal calf serum (FCS) exhibits a significant proportion in S phase (32

InChiKey: ZCOLJUOHXJRHDI-CMWLGVBASA-N

Bedaquiline Catalog No.:M8161-2 Euglycemic human islet transplantation modelBedaquiline, also known as TMC207 and R207910, is a diarylquinoline anti tuberculosis drug, which was discovered by a team led by Koen Andries at Janssen Pharmaceutica. Bedaquiline blocks the proton pump for ATP synthase of mycobacteria. ATP production is required for cellular energy production and its loss leads to cell death, even in dormant or nonreplicating mycobacteria. It is the first member of a new class of drugs called the diarylquinolines.